Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genetics of the mammalian phenylalanine hydroxylase system. Studies of human liver phenylalanine hydroxylase subunit structure and of mutations in phenylketonuria.
|
496890 |
1979 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Validation of PAH genotype-based predictions of metabolic phenylalanine hydroxylase deficiency phenotype: investigation of PKU/MHP patients from Lithuania.
|
12640344 |
2003 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We report prenatal diagnosis of phenylketonuria by linkage analysis of the markers linked to the phenylalanine hydroxylase (PAH) gene.
|
16456253 |
2005 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Since the hypothesis that classical PKU is caused by structural mutations in the phenylalanine hydroxylase gene itself rather than through some transregulatory mechanisms has recently been confirmed by gene mapping, the PKU locus in man is determined to be on chromosome 12.
|
6547271 |
1984 |
Classical phenylketonuria
|
0.800 |
Biomarker
|
disease |
BEFREE |
Common metabolic (blood Phe levels) and individual (age) factors implicated in the assessment of PKU outcome account only marginally and transiently for the variability of neopterin and biopterin excretion in PKU patients.
|
28540433 |
2017 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Polymorphic DNA haplotypes at the phenylalanine hydroxylase locus and their relation to phenotype in Swedish phenylketonuria families.
|
1674714 |
1991 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The recent demonstration that the mutation responsible for classic phenylketonuria associated with haplotype 3 is not present in mutant alleles of other haplotypes provides unambiguous evidence that there are multiple mutations in the phenylalanine hydroxylase gene and supports the hypothesis that different combinations of mutant alleles may be responsible for the clinical diversity of phenylketonuria.
|
2878985 |
1987 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In contrast, discordant metabolic phenotypes (mild PKU and MHP) were observed in two unrelated patients bearing the same R261Q/P211T genotype, a finding which underscores the complex relationship linking genotype to phenotype in PAH deficiency.
|
11708866 |
2001 |
Classical phenylketonuria
|
0.800 |
Biomarker
|
disease |
BEFREE |
We have recently identified four compounds (I-IV) with pharmacological chaperone effect for PAH and phenylketonuria mutants (Pey et al.(2008) J. Clin.Invest.118, 2858-2867).
|
20492352 |
2010 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAH(enu2) mouse model of phenylketonuria.
|
26822703 |
2016 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A comprehensive study of phenylalanine hydroxylase gene mutations in the Iranian phenylketonuria patients.
|
30389586 |
2019 |
Classical phenylketonuria
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population.
|
21147011 |
2011 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin.
|
19444284 |
2009 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The R408W mutation in the phenylalanine hydroxylase gene (PAH) of phenylketonuria patients occurs on haplotypes 2.3 and 1.8 in Europeans.
|
7833927 |
1994 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Identification of PAH gene mutations responsible for PAH deficiency will therefore be useful in the prediction of biochemical and clinical phenotypes in HPA patients.
|
23792259 |
2013 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
More than 200 mutations in the PAH gene are associated with PAH deficiency.
|
8828600 |
1996 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Thus, the phenylketonuria-associated PAH mutant R158Q had a coupling efficiency of about 80%, compared to the wild-type enzyme under similar conditions.
|
15963939 |
2005 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The PAH mutant proteins (R158Q, I174T and R408W) that result in the classical phenylketonuria (PKU) phenotype expressing 0.2-1.8% of the wild type PAH activity when using phenylalanine as substrate were found to have <0.1% of the wild type PAH activity when SCMC was used as the substrate.
|
19036622 |
2009 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria.
|
2883110 |
1987 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Polymorphic DNA haplotypes at the phenylalanine hydroxylase locus in prenatal diagnosis of phenylketonuria.
|
2868252 |
1986 |
Classical phenylketonuria
|
0.800 |
Biomarker
|
disease |
BEFREE |
Phenylketonuria is a metabolic disorder that results from a deficiency of the hepatic enzyme phenylalanine hydroxylase.
|
2014036 |
1991 |
Classical phenylketonuria
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Phenylalanine hydroxylase (PAH) regulates phenylalanine (Phe) levels in mammals to prevent neurotoxicity resulting from high Phe concentrations as observed in genetic disorders leading to hyperphenylalaninemia and phenylketonuria.
|
30287685 |
2018 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In vitro residual activities in 20 variants of phenylalanine hydroxylase and genotype-phenotype correlation in phenylketonuria patients.
|
31102715 |
2019 |
Classical phenylketonuria
|
0.800 |
Biomarker
|
disease |
BEFREE |
Consequently, in every newborn infant with positive Guthrie test results, a rapid investigation of BH4 metabolism should be accomplished in order to differentiate between phenylalanine-hydroxylase deficiencies (phenylketonuria, mild hyperphenylalaninemia, transient hyperphenylalaninemia) and BH4 deficiencies.
|
6142937 |
1984 |
Classical phenylketonuria
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Silent mutations in the phenylalanine hydroxylase gene as an aid to the diagnosis of phenylketonuria.
|
1682495 |
1991 |